Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Late Quaternary climate impact on the genome of the woodland strawberry (Fragaria vesca), a perennial herb.

Communications biology·2026

Same author

Developmental processes in the Rosaceae through the lens of DNA and RNA methylation.

Planta·2025

Same author

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

Genomic selection strategies for clonally propagated crops.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2023

Same author

High-Density Linkage Map Construction and QTL Identification in a Diploid Blueberry Mapping Population.

Frontiers in plant science·2021

Same author

Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancer.

World journal of clinical oncology·2021

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Adjuvant therapy in the elderly: making the right decision.

Hyman B Muss¹, Laura Biganzoli, Daniel J Sargent

¹University of Vermont and Vermont Cancer Center, Burlington, VT 05401, USA. hyman.muss@uvm.edu

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|May 10, 2007

Summary

Older adults with solid tumors can benefit from adjuvant chemotherapy if they have a life expectancy over 5 years. Treatment decisions require careful consideration of comorbidities to maximize survival benefits.

Related Experiment Videos

Last Updated: Jul 15, 2026

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Area of Science:

Oncology
Geriatric Medicine

Background:

Adjuvant chemotherapy improves survival in breast, colon, and non-small-cell lung cancer.
Older patients are often excluded from trials and undertreated with adjuvant chemotherapy.

Purpose of the Study:

To review the benefits of adjuvant therapy in older patients with solid tumors.
To discuss comorbidity's role in treatment decisions for elderly cancer patients.

Main Methods:

Literature review focusing on adjuvant chemotherapy in older adults.
Analysis of factors influencing treatment selection in elderly cancer patients.

Main Results:

Older patients with a life expectancy >5 years may benefit significantly from adjuvant therapies.
Comorbidities can limit life expectancy and negate chemotherapy benefits.

Conclusions:

Adjuvant chemotherapy can be beneficial for select older cancer patients.
Individualized treatment decisions considering comorbidities are crucial for elderly patients.